Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
age associated memory impairment
aggression
agitation
algorithm
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, driving with
Alzheimer's disease, early symptoms
Alzheimer's disease, patient awareness of
Alzheimer's disease, preclinical
Alzheimer's disease, prognosis of
Alzheimer's disease, risk factors in
Alzheimer's disease, telling patient diagnosis of
Alzheimer's disease, treatment of
amyloid beta protein
anosognosia
anticholinesterase
anticoagulant, treatment
antidepressant
antiphospholipid antibodies
anxiety
atypical
behavior
behavior, combative
behavioral disorder
biologic markers
carbamazepine
caregiver
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, venography
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebral venous thrombosis, etiology
cerebral venous thrombosis, recurrent
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, prevention of
cerebrovascular accident, thrombolytic agents in treatment
children
complications
controversies in neurology
craniectomy, decompressive
D-dimer
degenerative diseases of CNS
dementia
dementia, diagnostic evaluation of
dementia, driving with
dementia, early detection
dementia, preexisting in stroke patient
dementia, screening for
dementia, treatment of
donepezil
driving
driving restrictions
driving test
dural sinus thrombosis
dying
efficacy
endovascular therapy
epidemiology of neurology
ethics in neurology
evidence-based research
exercise
Factor V Leiden
fibrinolytic agents
fibrinolytic agents, intra-venous local infusion
gadolinium
galantamine
headache
hydrocephalus
incidence
intellectual deficit
intracranial pressure, increased
level of consciousness, decreased
medical-legal aspects of neurology
memory
memory, impairment of
memory, impairment of, subjective
mild cognitive impairment
mild cognitive impairment converting to Alzheimer's disease
Mini Mental Status Examination
mortality
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, venography
neuroleptic
neuroleptic, atypical
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic examination, focal
neurologic symptoms
olanzapine
old age, driving and
old age, neurology of
oral contraceptives
patient information and support
pitfalls
practice guidelines
preclinical
pregnancy, neurologic complications in
prethrombotic state
prognosis
protein C deficiency
protein S deficiency
psychological testing
psychosis
psychotic behavior
quetiapine
review article
risk factors
risk factors, modification
risperidone
rivastigmine
safety
seizure
selective serotonin reuptake inhibitors
suicide
tissue plasminogen activator, intravenous
treatment of neurologic disorder
white matter disease
workup
Showing articles 350 to 400 of 1454 << Previous Next >>

Predictors of Driving Safety in Early Alzheimer Disease
Neurol 72:521-527, Dawson,J.D.,et al, 2009

Rapidly Progressive Neurodegenerative Dementias
Arch Neurol 66:201-207, Josephs,K.A.,et al, 2009

Incidental MRI Anomalies Suggestive of Multiple Sclerosis: The Radiologically Isolated Syndrome
Neurol 72:800-805,780, Okuda,D.T.,et al, 2009

Cerebral Microbleed Preceding Symptomatic Intracerebral Hemorrhage in a Stroke-Free Person
Neurol 72:763-765, Vernooij,M.W.,et al, 2009

Genetic Aspects of Alzheimer Disease
The Neurologist 15:80-86, Williamson,J.,et al, 2009

Cerebrospinal Fluid Angiotensin-Converting Enzyme for Diagnosis of Central Nervous System Sarcoidosis
The Neurologist 15:108-111, Khoury,J.,et al, 2009

Alzheimers Disease
BMJ 338:467-471, Burns,A. &Iliffe,S., 2009

Prescribe Prednisolone Alone for Bells Palsy Diagnosed Within 72 Hours of Symptom Onset
BMJ 338:410-411, Madhok,V.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

In Vivo Mapping of Amyloid Toxicity in Alzheimer Disease
Neurol 72:1504-1511, Frisoni,B.G.,et al, 2009

Cost-Effectiveness of Patient Selection Using Penumbral-Based MRI for Intravenous Thrombolysis
Stroke 40:1710-1720, Earnshaw,S.R.,et al, 2009

Identifying Patients at High Risk for Poor Outcomes After Intra-Arterial Therapy for Acute Ischemic Stroke
Stroke 40:1780-1785, Hallevi,H.,et al, 2009

Donepezil Treatment of Patients with MCI: A 48-Week Randomized, Placebo-Controlled Trial
Neurol 72:1555-1561, Doody,R.S.,et al, 2009

Telemedicine Versus Telephone for Remote Emergency Stroke Consultations: A Critically Appraised Topic
The Neurologist 15:163-166, Capampngan,D.J.,et al, 2009

Long-Term Effects of the Concomitant Use of Memantine with Cholinesterase Inhibition in Alzheimer Disease
JNNP 80:600-607, Lopez,O.L.,et al, 2009

The Presentation and Clinical Course of Intracranial Developmental Venous Anomalies in Adults: A Systematic Review and Prospective, Population-Based Study
Stroke 40:1980-1985, Hon,J.M.L.,et al, 2009

Age, Neuropathology, and Dementia
NEJM 360:2302-2309, Savva,G.M.,et al, 2009

MR Mismatch Is Useful for Patient Selection for Thrombolysis: Yes
Stroke 40:2906-2907,2910, Fiebach,J.B. &Schellinger,P.D., 2009

Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor- Inhibitors
CID 49:924-927, Bradford, R.D.,et al, 2009

Fully-Automated Quantification of Regional Brain Volumes for Improved Detection of Focal Atrophy in Alzheimers Disease
AJNR 30:578-580, Brewer, J.B.,et al, 2009

Ischemic Stroke and ICU Care
Semin Neurol 28:645-656, Llinas, R, 2008

Stroke Syndrome Secondary to Hypercoagulability of Lung Cancer
Commun Oncol 5:595-596, Lim, B. & Henry, D.H., 2008

Superficial Siderosis: A Potential Diagnostic Marker of Cerebral Amyloid Angiopathy in Alzheimer Disease
Stroke 39:2894-2897,2699, Feldman,H.H.,et al, 2008

Alternative Medicine and Alzheimer Disease
The Neurologist 14:299-306, Kelley,B.J. &Knopman,D.S., 2008

Practice Parameter: The Diagnostic Evaluation and Treatment of Trigeminal Neuralgia (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the AAN & EFNS
Neurol 71:1183-1190, Gronseth,G.,et al, 2008

Medical Decision-Making Capacity in Mild Cognitive Impairment: A 3-Year Longitudinal Study
Neurol 71:1474-1480, Okonkwo,O.C.,et al, 2008

Symptomatic Intracerebral Hemorrhage and Recanalization After IV rt-PA: A Multicenter Study
Neurol 71:1304-1312, Saqqur,M.,et al, 2008

Agitation and Delirium at the End of Life
JAMA 300:2898-2910,2929, Breitbart,W. &Alici,Y., 2008

Prodromal Alzheimers Disease: Successive Emergence of the Clinical Symptoms
Ann Neurol 64:492-498,479, Amieva,H.,et al, 2008

A 24-Year-Old Woman with Intractable Seizures: Review of Surgery for Epilepsy
JAMA 300:2527-2538,2568, Schomer,D.I. &Black,P.M., 2008

Memory Problems in an Older Person
BMJ 337:1235-1236, Suresh,K.,et al, 2008

Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Arch Neurol 65:1509-1517, Aizenstein,H.J.,et al, 2008

Review of Tissue Plasminogen Activator, Ischemic Stroke, and Potential Legal Issues
Arch Neurol 65:1429-1433, Liang,B.A.,et al, 2008

Immunosuppressant Drugs for Myasthenia Gravis
JNNP 80:5-6, Hart,I.K.,et al, 2008

Rapidly Progressive Dementia
Ann Neurol 64:97-108, Geschwind,M.D.,et al., 2008

Effect of Demebon on Cognition, Activities of Daily Living, Behavior, and Global Function in Patients With Mild-To-Moderate Alzheimers Disease: A Randomised, Double-Blind, Placebo-Controlled Study
Lancet 372:207-215,179, Doody, R.S.,et al., 2008

Neurofibromatosis
JAMA 300:352, Torpy,J.M.,et al., 2008

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

The Logopenic/Phonological Variant of Primary Progressive Aphasia
Neurol 71:1227-1234, Gorno-Tempini,M.L.,et al, 2008

Assessment of �-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography with Carbon 11-Labeled Pittsburgh Compound B
Arch Neurol 65:1304-1309,1281, Leinonen,V.,et al, 2008

Variability of Brain Death Determination Guidelines in Leading US Neurologic Institutions
Neurol 70:284-289,252, Greer,D.M.,et al, 2008

Foreign Accent Syndrome as the Initial Sign of Primary Progressive Aphasia
JNNP 79:79-81, Luzzi,S.,et al, 2008

Risperidone, Haloperidol, and Placebo in the Treatment of Aggressive Challenging Behaviour in Patients With Intellectual Disability: A Randomised Controlled Trial
Lancet 371:57-63,9, Tyrer,P.,et al, 2008

NSAID Use and Dementia Risk in the Cardiovascular Health Study: Role of APOE and NSAID Type
Neurol 70:17-24, Szekely,C.A.,et al, 2008

Joint Effect of Stroke and APOE 4 on Dementia Risk: The Canadian Study of Health and Aging
Neurol 70:9-16,5, Jin,Y.P.,et al, 2008

A Risk Score for Unfavorable Outcome in Adults with Bacterial Meningitis
Ann Neurol 63:90-97, Weisfelt,M.,et al, 2008

Survival Times in People with Dementia: Analysis From Population Based Cohort Study With 14 Year Follow-Up
BMJ 336:258-262,225, Xie,J.,et al, 2008

Influence of the Stroke Code Activation Source on the Outcome of Acute Ischemic Stroke Patients
Neurol 70:1238-1243,1232, P�rez de la Ossa,N.,et al, 2008

A longitudinal Study of Drivers With Alzheimer Disease
Neurol 70:1171-1178, Ott, B.R.,et al, 2008

Dipyridamole for Preventing Stroke and Other Vascular Events in Patients With Vascular Disease: An Update
Stroke 39:1397-1398, De Schryver,E.L.L.M.,et al, 2008



Showing articles 350 to 400 of 1454 << Previous Next >>